模式识别增强
模式识别增强（Pattern recognition enhancement）被定义为一个人在模糊刺激中识别模式的能力和倾向的增加哦。
| 图片示例 | 描述 |
|---|---|
 |
云中的脸，作者：Neil Usher - 这张图片是模式识别增强的一个典型例子呢。 |
看到像人脸一样的图案是人类与生俱来的能力，在日常生活中非常普遍，科学文献里管这叫“幻想性视错觉”（pareidolia）喵。常见的例子包括在车头看到“脸”，或者在云朵里看到各种奇奇怪怪的东西呢。
在这种效应下，图案会比平时清醒状态下要显著得多哦。比如，风景里可能会出现细节惊人的图像，日常物品看起来可能像张脸，云朵也可能变成梦幻的物体，而这一切都不需要真正的视觉改变就会发生呢。一旦在某个物体或景观中感知到了图像，大脑可能会通过一种叫变形的幻觉状态来进一步夸大这种识别，这就不只是幻想性视错觉了，而是变成了标准的视觉幻觉喵。
模式识别增强通常伴随着其他效应，比如视觉锐度增强和颜色增强呢。它最常见于服用轻微剂量的致幻剂化合物，比如LSD、赛洛西宾和麦斯卡林哦。
图像示例
| 图片 | 描述 |
|---|---|
 |
树皮中的脸，作者：Bev Doolittle |
 |
树皮上的笑脸，作者：Chelsea Morgan |
 |
骷髅花，作者：匿名 |
| 塔之眼，作者：Davide Lombardi | |
| 缺席的美人鱼，作者：Octavio Ocampo | |
| 视错觉，作者：Oleg Shuplyak | |
 |
森林有眼，作者：Bev Doolittle |
 |
云中的脸，作者：Denis Farmer |
| 屋顶上眯起的眼睛，作者：匿名 | |
| 视错觉，作者：Oleg Shuplyak |
体验报告
在我们的体验索引中，描述了这种效应的轶事报告包括：
- Experience: 15mg 2C-B (oral) - A pleasant low-dose evening with Nexus_-_A_pleasant_low-dose_evening_with_Nexus)
- Experience: 200µg 1P-LSD (sublingual) + 12mg CBD - The Vortex of Empathy_%2B_12mg_CBD_-_The_Vortex_of_Empathy)
- Experience: 22mg 2C-B (oral) / 100ug 1P-LSD (sublingual) - My first time tripping alone (2 days in a row)/_100ug_1P-LSD(sublingual)-_My_first_time_tripping_alone(2_days_in_a_row))
- Experience: 25mg 2C-E (oral) - A mindblowing experience_-_A_mindblowing_experience)
- Experience: 80mg EPT - Slight improvement
- Experience:0.75g MDMA - Possibly some MDA through metabolisation?
- Experience:1000 Morning Glory seeds - Rediscovering the Self
- Experience:120µg LSD - First Bad Acid Trip, Psychosis
- Experience:150mg MDMA + 20mg 2C-B - I designed it this way myself
- Experience:2.5g Psilocybe Cubensis B+ strain - epiphany of nondualistic reality
- Experience:20mg (insufflated) - permanent all-encompassing states of unity and interconnectedness_-_permanent_all-encompassing_states_of_unity_and_interconnectedness)
- Experience:20mg - I looked up and saw an angry god-like figure made of clouds glaring down at me
- Experience:250 seeds - Harsh body load
- Experience:25mg - A labyrinth of organs and a storybook walk
- Experience:2C-P (approx. 35mg) - Asymmetrical Terror and the Geometric Sea_-_Asymmetrical_Terror_and_the_Geometric_Sea)
- Experience:2mg 25C-NBOMe - Experimental trip to test personal limits of NBOMes
- Experience:3 Grams of Mushrooms - Reset on my Life, Experiencing Satori and the Cosmic Perspective
- Experience:3.5g psilocybe cubensis - Relinquishing of Material Chains/Fear and Desolation
- Experience:300µg LSD - Togetherness and the Silent Dusk
- Experience:4-HO-DET (20 mg, oral) - Tripping for my birthday_-_Tripping_for_my_birthday)
- Experience:4.5g - The Grand Introduction to Beauty and Fear
- Experience:40mg - Brothermind and the Forest's Hand
- Experience:5g Mushrooms - Failed attempt at a Terence Mckenna style trip.
- Experience:BK-2C-B - Various experiences
- Experience:LSD (230 ug) - An amazing adventure by vikilikepsych_-_An_amazing_adventure_by_vikilikepsych)
- Experience:Mushrooms and Snuff Films -- Trip Report (3.5 grams))
- Experience:Unknown dosage / 1 tab DOC - Psychedelia Turned Into Stimulant Psychosis
- Experience:Unknown dosage / 3 tabs - Ego death and a total break through in the snow
- Experience:~150mg MDA(oral) - a case of mistaken identity_-_a_case_of_mistaken_identity)
另见
外部链接
参考文献
- ↑ Liu, Jiangang; Li, Jun; Feng, Lu; Li, Ling; Tian, Jie; Lee, Kang (2014). "Seeing Jesus in toast: Neural and behavioral correlates of face pareidolia". Cortex. 53: 60–77. doi:10.1016/j.cortex.2014.01.013. ISSN 0010-9452.
- ↑ Hadjikhani, Nouchine; Kato, Masaharu; Mugitani, Ryoko (2015). "Pareidolia in Infants". PLOS ONE. 10 (2): e0118539. doi:10.1371/journal.pone.0118539. ISSN 1932-6203.
- ↑ Abraham, Henry David (1983). "Visual Phenomenology of the LSD Flashback". Archives of General Psychiatry. 40 (8): 884. doi:10.1001/archpsyc.1983.01790070074009. ISSN 0003-990X.
- ↑ Belser, Alexander B.; Agin-Liebes, Gabrielle; Swift, T. Cody; Terrana, Sara; Devenot, Neşe; Friedman, Harris L.; Guss, Jeffrey; Bossis, Anthony; Ross, Stephen (2017). "Patient Experiences of Psilocybin-Assisted Psychotherapy: An Interpretative Phenomenological Analysis". Journal of Humanistic Psychology. 57 (4): 354–388. doi:10.1177/0022167817706884. ISSN 0022-1678.
- ↑ Halberstadt, Adam L. (2015). "Recent advances in the neuropsychopharmacology of serotonergic hallucinogens". Behavioural Brain Research. 277: 99–120. doi:10.1016/j.bbr.2014.07.016. ISSN 0166-4328.
- ↑ Papoutsis, Ioannis; Nikolaou, Panagiota; Stefanidou, Maria; Spiliopoulou, Chara; Athanaselis, Sotiris (2014). "25B-NBOMe and its precursor 2C-B: modern trends and hidden dangers". Forensic Toxicology. 33 (1): 1–11. doi:10.1007/s11419-014-0242-9. ISSN 1860-8965.
- ↑ Bersani, Francesco Saverio; Corazza, Ornella; Albano, Gabriella; Valeriani, Giuseppe; Santacroce, Rita; Bolzan Mariotti Posocco, Flaminia; Cinosi, Eduardo; Simonato, Pierluigi; Martinotti, Giovanni; Bersani, Giuseppe; Schifano, Fabrizio (2014). "25C-NBOMe: Preliminary Data on Pharmacology, Psychoactive Effects, and Toxicity of a New Potent and Dangerous Hallucinogenic Drug". BioMed Research International. 2014: 1–6. doi:10.1155/2014/734749. ISSN 2314-6133.